FdaApplication
ANDA 203593
Identifiers
- fda_app_no: ANDA203593
Properties
| Property | Value |
|---|---|
| applicant_name | WATSON LABORATORIES INC |
| application_type | ANDA |
| approval_date | 2016-10-11 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM | DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM | 3MG,N/A;0.02MG,N/A;0.451MG,0.451MG | TABLET;ORAL |
1 product